Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2017)

Updated

Enanta Pharmaceuticals (ENTA) posted Current Leases of $79,000 for fiscal Q4 2017 (quarter ended Sep 30, 2017), up 8.2% from $73,000 a year earlier and up 5.3% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2017) Analysis & Trends

Since fiscal Q4 2016, Enanta Pharmaceuticals has reported Current Leases for 5 quarters.

  • In prior fiscal years, Enanta Pharmaceuticals' Current Leases was $73,000 in FY2016.
  • According to Business Quant data, Current Leases for the three prior fiscal quarters was $75,000 (Q3 2017), $75,000 (Q2 2017) and $75,000 (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 79,000.00
Jun 30, 2017 75,000.00
Mar 31, 2017 75,000.00
Dec 31, 2016 75,000.00
Sep 30, 2016 73,000.00
API Access

Enanta Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ENTA&period=max&api_key=YOUR_API_KEY